Monogram Biosciences
Monogram Biosciences, Inc. (formerly ViroLogic Inc.) is an international biotechnology laboratory located in South San Francisco, California, USA and is a subsidiary of LabCorp. Monogram develops and markets assays to help guide and improve the treatment of infectious diseases (including HIV and Hepatitis) and cancer.
| Company type | Subsidiary |
|---|---|
| Industry | Biotechnology |
| Headquarters | South San Francisco, California |
| Products | PhenoSense, PhenoSense GT, Trofile, GeneSeq, VeraTag, HERmark |
Number of employees | 379 (2008) |
| Parent | LabCorp |
| Website | http://www.monogrambio.com/ |
Virologic was founded in 1996 by Daniel Capon, Ph.D., Martin Goldstein and Robert S. Capon. The company went public (NASDAQ: VLGC) in 2000.[1]
Monogram was acquired by Laboratory Corporation of America in June 2009.[2]
References
- SEC. "Monogram Biosciences, Inc. 2000 Quarterly Report 10-Q". SEC.report. p. 10. Retrieved 2020-06-22.
- "LabCorp Successfully Completes Acquisition of Monogram Biosciences, Inc". Business Wire. Retrieved 28 May 2010.
External links
- Official website
- Baseline HIV Type 1 Coreceptor Tropism Predicts Disease Progression
- Four Studies Affirm Significance Of Monogram's Trofile(TM) HIV Co-Receptor Tropism Assay
- Accuracy of Monogram's Trofile Assay in Determining Tropism and New Tropism Assays in Development
- Trofile Bests SensiTrop as Most Reliable Tropism Test
- Monogram Biosciences teams up with Pfizer for HIV treatment
- Monogram Biosciences Launches New "Trofile" HIV Co-receptor Tropism Test to Select Patients Eligible to User CCR5 Antagonist Maraviroc (Selzentry)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.